Brief: Senzime Expects To Reach Revenues Of SEK 250-350 Mln By 2026

Senzime AB (publ)

26/08/2024 07:19

Aug 26 (Reuters) - Senzime AB (publ)  SEZI.ST :
    * SENZIME PROVIDES MARKET UPDATE AND OUTLINES HIGH GROWTH
AMBITIONS
    * UPDATE IS RESULT OF A RAPIDLY EXPANDING ADDRESSABLE
MARKET, NEW
SUPPORTIVE EU AND US CLINICAL GUIDELINES
    * UPDATE IS RESULT OF  STRONG CLINICAL ADOPTION OF EMG-BASED
NEUROMUSCULAR MONITORING TECHNOLOGY IN PREDOMINATELY US, JAPAN
AND SOUTH KOREA
    * SHORT-TERM GROWTH GUIDANCE: BY 2026, REACH REVENUES OF
250-350
MSEK AND BE CASH FLOW POSITIVE DURING YEAR
    * LONGER-TERM AMBITIONS: 5-7 YEAR MILESTONE TO REACH
REVENUES
EXCEEDING SEK 1 BILLION.
    * ESTIMATES THAT GLOBAL MARKET FOR EMG-BASED NEUROMUSCULAR
MONITORING WILL GROW WITH A STEEP TRAJECTORY OVER NEXT DECADE
    * SENZIME ESTIMATES THAT GLOBAL MARKET FOR EMG-BASED
NEUROMUSCULAR
MONITORING WILL GROW WITH A STEEP TRAJECTORY OVER NEXT DECADE

Source text for Eikon:  ID:nMFNgmBtS 
Further company coverage:  SEZI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))